Skip to main content
Fig. 5 | BMC Complementary Medicine and Therapies

Fig. 5

From: An in vitro study of an Artocarpus heterophyllus substance as a hepatitis C antiviral and its combination with current anti-HCV drugs

Fig. 5

The TLC pattern of sub-fraction 1–7 of FR3T. RP-18 TLC was used as stationary phase and methanol:water (95:5, v/v) as a mobile phase. (1) A. heterophyllus dichloromethane extract, (2) FR3T1, (3) FR3T2, (4) FR3T3, (5) FR3T4 (6) FR3T5, (7) FR3T6, (8) FR3T7 sub-fraction. Detection under A UV 254 nm, B UV 365 nm, C sprayed with 10% sulfuric acid and heated at 105 °C for 5 min then observed under UV 365 nm D observed under white lamp

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us